Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Jacobs

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Clinical Chemistry and Laboratory Medicine|March 31, 2016
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interferenceChristopher McCudden, Amy E Axel, Dominique Slaets, et al.
The Netherlands Journal of Medicine|October 5, 2019
Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic optionsK Amaador, H Peeters, M C Minnema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patientsJoannes F M Jacobs, Cornelis J A Punt, W Joost Lesterhuis, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2024
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myelomaPieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, et al.
Nature Communications|August 22, 2018
Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cellsFlorian Wimmers, Nikita Subedi, Nicole van Buuringen, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patientsJoannes F M Jacobs, Erik H J G Aarntzen, Lenny A G Sibelt, et al.
International Journal of Cancer|September 15, 2010
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patientsIngrid M E Desar, J Hans F M Jacobs, Christina A Hulsbergen-vandeKaa, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigueHetty Prinsen, Hanneke W M van Laarhoven, Jeanette M Pots, et al.
Scientific Reports|March 28, 2017
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patientsFlorian Wimmers, Nienke de Haas, Anja Scholzen, et al.
Clinical Chemistry and Laboratory Medicine|February 1, 2026
Laboratory solution to diagnose and monitor atypical IgG4-mediated anti-GBM diseaseJoannes F M Jacobs, Annechien J A Lambeck, Rosa G M Lammerts, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Clinical Chemistry and Laboratory Medicine|March 31, 2016
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interferenceChristopher McCudden, Amy E Axel, Dominique Slaets, et al.
The Netherlands Journal of Medicine|October 5, 2019
Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic optionsK Amaador, H Peeters, M C Minnema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patientsJoannes F M Jacobs, Cornelis J A Punt, W Joost Lesterhuis, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2024
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myelomaPieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, et al.
Nature Communications|August 22, 2018
Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cellsFlorian Wimmers, Nikita Subedi, Nicole van Buuringen, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2008
Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patientsJoannes F M Jacobs, Erik H J G Aarntzen, Lenny A G Sibelt, et al.
International Journal of Cancer|September 15, 2010
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patientsIngrid M E Desar, J Hans F M Jacobs, Christina A Hulsbergen-vandeKaa, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigueHetty Prinsen, Hanneke W M van Laarhoven, Jeanette M Pots, et al.
Scientific Reports|March 28, 2017
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patientsFlorian Wimmers, Nienke de Haas, Anja Scholzen, et al.
Clinical Chemistry and Laboratory Medicine|February 1, 2026
Laboratory solution to diagnose and monitor atypical IgG4-mediated anti-GBM diseaseJoannes F M Jacobs, Annechien J A Lambeck, Rosa G M Lammerts, et al.
Pageof 11